BELLEVUE, Wash.–(BUSINESS WIRE)–Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the Company or Novo Integrated Sciences), a provider of multidisciplinary primary healthcare, today reported financial results for its fiscal third quarter period ended May…

Click here to view the original article.